Aberrant White Matter Development in Cerebral Visual Impairment: A Proposed Mechanism for Visual Dysfunction

Corinna M Bauer1,2, Lotfi B Merabet1

  • 1Laboratory for Visual Neuroplasticity, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114, USA.

PubMed

Insights

Cerebral visual impairment (CVI) involves altered white matter pathways, particularly in those with periventricular leukomalacia (PVL). This study found reduced tract volume and increased diffusion metrics in CVI-PVL patients, suggesting etiology-specific white matter changes.

Area of Science:

  • Neuroscience
  • Radiology
  • Pediatrics

Background:

  • Cerebral visual impairment (CVI) is a leading cause of pediatric visual dysfunction due to early brain injury.
  • White matter pathway alterations may underlie CVI, despite heterogeneous patient presentations.
  • Diffusion tractography can explore these white matter differences.

Purpose of the Study:

  • To investigate white matter pathway differences in adults with CVI compared to controls.
  • To examine tract volume, quantitative anisotropy (QA), and diffusion metrics (MD, AD, RD) in visual streams.
  • To explore etiology-specific differences within the CVI cohort.

Main Methods:

  • High angular resolution diffusion imaging (HARDI) data from 10 CVI patients and 17 controls.
  • Virtual reconstruction of visual stream white matter tracts (ILF, IFOF, VOF, SLF).
  • Comparison of tract volume, MD, AD, and RD between groups, with secondary ANOVA for etiology.

Main Results:

  • Significant reductions in tract volume in the CVI-PVL group compared to controls and CVI-nonPVL.
  • Widespread increases in QA, MD, and AD in CVI-PVL compared to controls.
  • Mixed effects observed in the CVI-nonPVL group, indicating varied white matter changes.

Conclusions:

  • Preliminary evidence suggests aberrant development of white matter fasciculi in CVI.
  • White matter changes in CVI may be influenced by the underlying cause, such as periventricular leukomalacia (PVL).
  • Larger sample sizes and behavioral testing are needed to fully understand CVI's white matter integrity and visual dysfunction.
Abstract